Attached files
| file | filename |
|---|---|
| 10-K - ARCT 10-K 20201231 - Arcturus Therapeutics Holdings Inc. | arct-10k_20201231.htm |
| EX-32.3 - EX-32.3 - Arcturus Therapeutics Holdings Inc. | arct-ex323_15.htm |
| EX-32.2 - EX-32.2 - Arcturus Therapeutics Holdings Inc. | arct-ex322_9.htm |
| EX-32.1 - EX-32.1 - Arcturus Therapeutics Holdings Inc. | arct-ex321_6.htm |
| EX-31.3 - EX-31.3 - Arcturus Therapeutics Holdings Inc. | arct-ex313_8.htm |
| EX-31.2 - EX-31.2 - Arcturus Therapeutics Holdings Inc. | arct-ex312_10.htm |
| EX-31.1 - EX-31.1 - Arcturus Therapeutics Holdings Inc. | arct-ex311_13.htm |
| EX-10.30 - EX-10.30 - Arcturus Therapeutics Holdings Inc. | arct-ex1030_393.htm |
| EX-10.29 - EX-10.29 - Arcturus Therapeutics Holdings Inc. | arct-ex1029_392.htm |
| EX-4.1 - EX-4.1 - Arcturus Therapeutics Holdings Inc. | arct-ex41_391.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
|
|
(1) |
Registration Statement (Form S-4 No. 333-230353) of Arcturus Therapeutics Holdings Inc., |
|
|
(2) |
Registration Statement (Form S-8 No. 333-232272) pertaining to the Arcturus Therapeutics Holdings Inc. 2019 Omnibus Equity Incentive Plan, |
|
|
(3) |
Registration Statement (Form S-8 No. 333-240397) pertaining to the Arcturus Therapeutics Holdings Inc. Amended and Restated 2019 Omnibus Equity Incentive Plan, and |
|
|
(4) |
Registration Statements (Form S-3 Nos. 333-232281, 333-235475, 333-237703, 333-238139, 333-235475 and 333-251175) of Arcturus Therapeutics Holdings Inc.; |
of our reports dated March 1, 2021, with respect to the consolidated financial statements of Arcturus Therapeutics Holdings Inc., and the effectiveness of internal control over financial reporting of Arcturus Therapeutics Holdings Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2020.
|
|
/s/ Ernst & Young LLP |
|
San Diego, California |
|
|
March 1, 2021 |
|